[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ang et al., 2020 - Google Patents

Silica-coated Mn-doped ZnS nanocrystals for cancer theranostics

Ang et al., 2020

View PDF
Document ID
8471298832016944490
Author
Ang E
Zeng J
Subramanian G
Chellappan V
Sudhaharan T
Padmanabhan P
Gulyás B
Tamil Selvan S
Publication year
Publication venue
ACS Applied Nano Materials

External Links

Snippet

Doped nanocrystals such as manganese-doped zinc sulfide (ZnS: Mn) are useful nanomedicine probes for cancer cell labeling and anticancer drug delivery. However, the synthesis and retention of fluorescence of these nanocrystals is highly indispensable for …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle

Similar Documents

Publication Publication Date Title
Zhang et al. Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications
Ang et al. Silica-coated Mn-doped ZnS nanocrystals for cancer theranostics
Chen et al. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics
Xu et al. New generation cadmium-free quantum dots for biophotonics and nanomedicine
Chen et al. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy
Li et al. Heterodimers made of upconversion nanoparticles and metal–organic frameworks
Muhr et al. Upconversion nanoparticles: from hydrophobic to hydrophilic surfaces
Lv et al. Integration of upconversion nanoparticles and ultrathin black phosphorus for efficient photodynamic theranostics under 808 nm near-infrared light irradiation
Mauro et al. Functionalization of metal and carbon nanoparticles with potential in cancer theranostics
Selvan et al. Functional and multifunctional nanoparticles for bioimaging and biosensing
Cai et al. Self-assembled upconversion nanoparticle clusters for NIR-controlled drug release and synergistic therapy after conjugation with gold nanoparticles
Louis et al. Nanosized hybrid particles with double luminescence for biological labeling
Yang et al. A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles
Erogbogbo et al. Biocompatible magnetofluorescent probes: luminescent silicon quantum dots coupled with superparamagnetic iron (III) oxide
Ryvolova et al. Modern micro and nanoparticle-based imaging techniques
Cheng et al. Bottom-up synthesis of metal-ion-doped WS2 nanoflakes for cancer theranostics
Li et al. Bright, magnetic NIR-II quantum dot probe for sensitive dual-modality imaging and intensive combination therapy of cancer
Shibu et al. Photouncaging nanoparticles for MRI and fluorescence imaging in vitro and in vivo
Yong et al. Imaging pancreatic cancer using bioconjugated InP quantum dots
Muhammed et al. Growth of in situ functionalized luminescent silver nanoclusters by direct reduction and size focusing
Vivero-Escoto et al. Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications
Lin et al. Water-soluble chitosan-quantum dot hybrid nanospheres toward bioimaging and biolabeling
Meng et al. Confinement of AuAg NCs in a pomegranate-type silica architecture for improved copper ion sensing and imaging
Singh et al. Development of iron-doped silicon nanoparticles as bimodal imaging agents
Zheng et al. Outer-frame-degradable nanovehicles featuring near-infrared dual luminescence for in vivo tracking of protein delivery in cancer therapy